106 related articles for article (PubMed ID: 17646696)
1. Treatment results of stroke patients aged >80 years receiving intravenous rt-PA.
Jauss M; Allendorfer J; Stolz E; Schutz HJ; Misselwitz B
Cerebrovasc Dis; 2007; 24(2-3):305-6. PubMed ID: 17646696
[No Abstract] [Full Text] [Related]
2. Characteristics and outcome of patients with early complete neurological recovery after thrombolysis for acute ischemic stroke.
Blinzler C; Breuer L; Huttner HB; Schellinger PD; Schwab S; Köhrmann M
Cerebrovasc Dis; 2011; 31(2):185-90. PubMed ID: 21160181
[TBL] [Abstract][Full Text] [Related]
3. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy.
Toni D; Lorenzano S; Agnelli G; Guidetti D; Orlandi G; Semplicini A; Toso V; Caso V; Malferrari G; Fanucchi S; Bartolomei L; Prencipe M
Cerebrovasc Dis; 2008; 25(1-2):129-35. PubMed ID: 18073466
[TBL] [Abstract][Full Text] [Related]
4. Comparison of partial (.6 mg/kg) versus full-dose (.9 mg/kg) intravenous recombinant tissue plasminogen activator followed by endovascular treatment for acute ischemic stroke: a meta-analysis.
Georgiadis AL; Memon MZ; Shah QA; Vazquez G; Suri MF; Lakshminarayan K; Qureshi AI
J Neuroimaging; 2011 Apr; 21(2):113-20. PubMed ID: 19909396
[TBL] [Abstract][Full Text] [Related]
5. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
6. Intravenous thrombolysis with rt-PA in acute stroke patients aged >or=80 years.
Toni D; Lorenzano S
Int J Stroke; 2009 Feb; 4(1):21-2. PubMed ID: 19236493
[No Abstract] [Full Text] [Related]
7. Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window.
Sølling C; Hjort N; Ashkanian M; Østergaard L; Andersen G
Cerebrovasc Dis; 2009; 27(3):223-9. PubMed ID: 19176954
[TBL] [Abstract][Full Text] [Related]
8. Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry.
Naganuma M; Koga M; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Okada Y; Hasegawa Y; Kario K; Okuda S; Nishiyama K; Minematsu K; Toyoda K
Cerebrovasc Dis; 2011; 31(2):123-9. PubMed ID: 21088392
[TBL] [Abstract][Full Text] [Related]
9. Intravenous thrombolysis in German stroke units before and after regulatory approval of recombinant tissue plasminogen activator.
Weimar C; Kraywinkel K; Maschke M; Diener HC;
Cerebrovasc Dis; 2006; 22(5-6):429-31. PubMed ID: 16912477
[TBL] [Abstract][Full Text] [Related]
10. Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis.
Bravo Y; Martí-Fàbregas J; Cocho D; Rodríguez-Yáñez M; Castellanos M; de la Ossa NP; Roquer J; Obach V; Maestre J; Martí-Vilalta JL
Cerebrovasc Dis; 2008; 26(2):126-33. PubMed ID: 18560215
[TBL] [Abstract][Full Text] [Related]
11. Routine thrombolysis with intravenous tissue plasminogen activator in acute ischaemic stroke patients aged 80 years or older: a single centre experience.
Uyttenboogaart M; Schrijvers EM; Vroomen PC; De Keyser J; Luijckx GJ
Age Ageing; 2007 Sep; 36(5):577-9. PubMed ID: 17405776
[No Abstract] [Full Text] [Related]
12. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?
Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH
Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959
[TBL] [Abstract][Full Text] [Related]
13. Is it justified to exclude patients with minor stroke from intravenous thrombolysis?
García-García J; Ayo-Martín O; Segura T
Int J Stroke; 2013 Apr; 8(3):E4. PubMed ID: 23489669
[No Abstract] [Full Text] [Related]
14. Successful intravenous rt-PA thrombolysis for a childhood cardioembolic stroke with Emery-Dreifuss muscular dystrophy.
Tanaka K; Uehara T; Sato K; Amano T; Minematsu K; Toyoda K
Cerebrovasc Dis; 2012; 33(1):92-3. PubMed ID: 22179395
[No Abstract] [Full Text] [Related]
15. [Subjects in the acute thrombolytic therapy by intravenous administration of rt-PA].
Suzuki A; Moroi J; Nakase T; Yoshioka S; Nagata K; Sato Y; Maeda T; Sawada M; Kobayashi N; Ogura N; Izumi M
No To Shinkei; 2006 Nov; 58(11):931-6. PubMed ID: 17133998
[No Abstract] [Full Text] [Related]
16. [Guidelines for intravenous thrombolytic therapy in acute ischemic stroke with special reference to those by the Ad Hoc Committee of the Japan Stroke Society].
Minematsu K
No To Shinkei; 2006 Nov; 58(11):915-21. PubMed ID: 17133996
[No Abstract] [Full Text] [Related]
17. [Intravenous thrombolysis with rt-PA in stroke: experience of the French military hospital of Toulon from September 2003 to June 2009].
Faivre A; Sagui E; Canini F; Wybrecht D; Bounolleau P; Grapperon J; Alla P; Valance J
Rev Neurol (Paris); 2010 Nov; 166(11):909-20. PubMed ID: 20452634
[TBL] [Abstract][Full Text] [Related]
18. Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke.
Kimura K; Iguchi Y; Yamashita S; Shibazaki K; Kobayashi K; Inoue T
J Neurol Sci; 2008 Apr; 267(1-2):57-61. PubMed ID: 17964602
[TBL] [Abstract][Full Text] [Related]
19. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion.
Hattenbach LO; Kuhli-Hattenbach C; Scharrer I; Baatz H
Am J Ophthalmol; 2008 Nov; 146(5):700-6. PubMed ID: 18718570
[TBL] [Abstract][Full Text] [Related]
20. Obstacles to the use of intravenous tissue plasminogen activator for acute ischemic stroke. Is time the only barrier?
Laloux P; Thijs V; Peeters A; Desfontaines P
Acta Neurol Belg; 2007 Dec; 107(4):103-7. PubMed ID: 18416282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
